Pages that link to "Q42845188"
Jump to navigation
Jump to search
The following pages link to Survival in elderly follicular lymphoma patients who receive frontline chemo‐immunotherapy (Q42845188):
Displaying 4 items.
- Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data (Q31036587) (← links)
- Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma (Q35525522) (← links)
- Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare (Q36210598) (← links)
- Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma. (Q53039853) (← links)